Market Cap 351.47M
Revenue (ttm) 154.01M
Net Income (ttm) -309.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -201.19%
Debt to Equity Ratio 0.00
Volume 5,785,900
Avg Vol 11,331,362
Day's Range N/A - N/A
Shares Out 297.85M
Stochastic %K 17%
Beta 1.86
Analysts Sell
Price Target $2.42

Latest News on PACB

Pacific Biosciences Names Jim Gibson Chief Financial Officer

Mar 27, 2025, 9:22 AM EDT - 6 days ago

Pacific Biosciences Names Jim Gibson Chief Financial Officer


Jim Gibson to join PacBio as Chief Financial Officer

Mar 27, 2025, 9:05 AM EDT - 6 days ago

Jim Gibson to join PacBio as Chief Financial Officer


PacBio Grants Equity Incentive Award to New Employee

Feb 14, 2025, 11:09 PM EST - 6 weeks ago

PacBio Grants Equity Incentive Award to New Employee


Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 6 weeks ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN TXG


Pacific Biosciences' Cost Cuts Won't Offset Rising Competition

Nov 12, 2024, 3:38 PM EST - 5 months ago

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition


PacBio to Present at Upcoming Investor Conferences

Nov 8, 2024, 4:05 PM EST - 5 months ago

PacBio to Present at Upcoming Investor Conferences